Literature DB >> 28453403

High Rate of Hepatitis B Virus Surface Antigenemia Among People Living with HIV/AIDS in Kakuri, Kaduna State, North West Nigeria.

Cornelius Arome Omatola1, Bernard Anyebe Onoja2, Temitope Thomas1.   

Abstract

Globally, increased incidence of liver disease caused by hepatitis B virus (HBV) is responsible for high morbidity and mortality among human immunodeficiency virus (HIV)-infected individuals. This is because both viruses share common routes of transmission. We determined prevalence of HBV-HIV coinfection and the influence of some risk factors on concomitant infection among people living with HIV in a treatment center in Kakuri, Kaduna State. Two hundred consenting individuals with HIV infection participated in the study. Fifty-seven males and 143 females were screened using commercial hepatitis B virus surface antigen (HBsAg) rapid membrane-based immunoassay kit (Fastep™ HBV). Seventeen patients tested positive to HBsAg (8.5%). There were more males (14.0%) than females (6.3%). Patients within 40-49 years of age had more coinfection (20.6%) compared to those older than 50 years who had the least prevalence (2.7%). Age of HBV/HIV coinfection was statistically significant (p = 0.02). Risk factors include no knowledge of HBV infection, sharing sharp objects, history of sexually transmitted diseases, history of surgeries, and no HBV immunization. High infection rate observed in this study underscores the need for public awareness, to educate people on modes of transmission. Routine screening is advocated for early HBV identification, as this will facilitate reduction of comorbidity and mortality resulting from opportunistic infection. Findings from this study support introduction of HBV vaccination as part of the Expanded Programme on Immunization in Nigeria.

Entities:  

Keywords:  HBV; HIV; coinfection; risk factors; seroprevalence

Mesh:

Substances:

Year:  2017        PMID: 28453403     DOI: 10.1089/vim.2016.0163

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  5 in total

Review 1.  Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.

Authors:  Mindie H Nguyen; Grace Wong; Edward Gane; Jia-Horng Kao; Geoffrey Dusheiko
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

2.  Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria.

Authors:  Olusegun Adewale Adeyemi; Ijeoma Uchenna Itanyi; Chamberline Ekene Ozigbu; Nicole Stadnick; Kiyomi Tsuyuki; Olanrewaju Olayiwola; Amaka Grace Ogidi; Chuka Eze; Gregory Alan Aarons; Chima Ariel Onoka; Echezona Edozie Ezeanolue
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

3.  Co-infection and Risk Factors Associated with STIs among Pregnant Women in Rural Health Facilities in Nigeria: A Retrospective Study.

Authors:  MaryJoy Umoke; Peter Sage; Tor Bjoernsen; Prince Christian Ifeanachor Umoke; Christian Ezeugworie; Daniel Ejiofor; Ogbonna Agha; Chioma Adaora Nwalieji; Rosemary N Onwe; Ifeanyi Emmanuel Nwafor; Obinna Jude Chukwu
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

4.  Hepatitis B virus infection among men who have sex with men and transgender women living with or at risk for HIV: a cross sectional study in Abuja and Lagos, Nigeria.

Authors:  Olusegun A Adeyemi; Andrew Mitchell; Ashley Shutt; Trevor A Crowell; Nicaise Ndembi; Afoke Kokogho; Habib O Ramadhani; Merlin L Robb; Stefan D Baral; Julie A Ake; Manhattan E Charurat; Sheila Peel; Rebecca G Nowak
Journal:  BMC Infect Dis       Date:  2021-07-06       Impact factor: 3.090

5.  Seroprevalence of HBV among people living with HIV in Anyigba, Kogi State, Nigeria.

Authors:  Cornelius Arome Omatola; Joshua Idofe; Martin-Luther Oseni Okolo; Patience Omebije Adejo; Mesach Maunta Maina; Joseph Abraham Oyiguh
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.